MedPath

STRIDES PHARMA, INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$1.4B
Website

Strides Pharma Gains FDA Approval for Generic Fluoxetine 60mg Tablets

Strides Pharma has received FDA approval for its generic Fluoxetine 60mg tablets, expanding its portfolio of this antidepressant drug.

Strides Pharma Receives USFDA Approval for Generic Theophylline Extended-Release Tablets

Strides Pharma's subsidiary secures USFDA approval for generic Theophylline extended-release tablets, used for chronic asthma and lung diseases.

© Copyright 2025. All Rights Reserved by MedPath